XML 41 R43.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Schedule of fair value assets and liabilities measured on recurring basis
The following table presents the balances of financial assets and liabilities measured at fair value on a recurring basis at the dates indicated (dollars in thousands):
 
Fair Value Measurements at September 30, 2019 Using
 
Balance at September 30,
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
Description
2019
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Securities available for sale:
 
 
 
 
 
 
 
Federal agencies and GSEs
$
121,256

 
$

 
$
121,256

 
$

Mortgage-backed and CMOs
135,201

 

 
135,201

 

State and municipal
43,855

 

 
43,855

 

Corporate
8,178

 

 
8,178

 

Total securities available for sale
$
308,490

 
$

 
$
308,490

 
$

Liabilities:
 
 
 
 
 
 
 
Derivative - cash flow hedges
$
3,477

 
$

 
$
3,477

 
$

 
Fair Value Measurements at December 31, 2018 Using
 
Balance at December 31,
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
Description
2018
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Securities available for sale:
 
 
 
 
 
 
 
Federal agencies and GSEs
$
134,039

 
$

 
$
134,039

 
$

Mortgage-backed and CMOs
111,867

 

 
111,867

 

State and municipal
79,902

 

 
79,902

 

Corporate
6,845

 

 
6,845

 

Total securities available for sale
$
332,653

 
$

 
$
332,653

 
$

Equity securities
$
1,830

 
$

 
$
1,830

 
$

Liabilities:
 
 
 
 
 
 
 
Derivative - cash flow hedges
$
804

 
$

 
$
804

 
$

Schedule of assets that were measured at fair value on a nonrecurring basis
The following table summarizes the Company's assets that were measured at fair value on a nonrecurring basis at the dates indicated (dollars in thousands):
 
Fair Value Measurements at September 30, 2019 Using
 
Balance at September 30,
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
Description
2019
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Impaired loans, net of valuation allowance
237

 

 

 
237

Other real estate owned, net
1,353

 

 

 
1,353

 
Fair Value Measurements at December 31, 2018 Using
 
Balance at December 31,
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
Description
2018
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Impaired loans, net of valuation allowance
171

 

 

 
171

Other real estate owned, net
869

 

 

 
869

Schedule of quantitative information of assets measured at Level 3
Quantitative Information About Level 3 Fair Value Measurements as of September 30, 2019 and December 31, 2018:
Assets
 
Valuation Technique
 
Unobservable Input
 

Rate
 
 
 
 
 
 
 
Impaired loans
 
Discounted appraised value
 
Selling cost
 
8.00%
 
 
Discounted cash flow analysis
 
Market rate for borrower (discount rate)
 
3.25% - 9.80%
 
 
 
 
 
 

Other real estate owned, net
 
Discounted appraised value
 
Selling cost
 
8.00%
Schedule of carrying values and estimated fair values of the entity's financial instruments
The carrying values and the exit pricing concept fair values of the Company's financial instruments at September 30, 2019 are as follows (dollars in thousands):
 
Fair Value Measurements at September 30, 2019 Using
 
 
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
 

 
Carrying Value
 
Level 1
 
Level 2
 
Level 3
 
Fair Value Balance
Financial Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
142,617

 
$
142,617

 
$

 
$

 
$
142,617

Securities available for sale
308,490

 

 
308,490

 

 
308,490

Restricted stock
8,621

 

 
8,621

 

 
8,621

Loans held for sale
5,646

 

 
5,646

 

 
5,646

Loans, net of allowance
1,791,689

 

 

 
1,782,466

 
1,782,466

Bank owned life insurance
27,612

 

 
27,612

 

 
27,612

Accrued interest receivable
6,610

 

 
6,610

 

 
6,610

 
 
 
 
 
 
 
 
 
 
Financial Liabilities:
 

 
 

 
 

 
 

 
 

Deposits
$
2,041,862

 
$

 
$
2,043,915

 
$

 
$
2,043,915

Repurchase agreements
38,924

 

 
38,924

 

 
38,924

Subordinated debt
7,521

 

 
7,583

 

 
7,583

Junior subordinated debt
28,003

 

 

 
24,150

 
24,150

Accrued interest payable
1,398

 

 
1,398

 

 
1,398

Derivative - cash flow hedges
3,477

 

 
3,477

 

 
3,477

The carrying values and the exit pricing concept fair values of the Company's financial instruments at December 31, 2018 are as follows (dollars in thousands):
 
Fair Value Measurements at December 31, 2018 Using
 
 
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
 

 
Carrying Value
 
Level 1
 
Level 2
 
Level 3
 
Fair Value Balance
Financial Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
64,255

 
$
64,255

 
$

 
$

 
$
64,255

Equity securities
1,830

 
 
 
1,830

 
 
 
1,830

Securities available for sale
332,653

 

 
332,653

 

 
332,653

Restricted stock
5,247

 

 
5,247

 

 
5,247

Loans held for sale
640

 

 
640

 

 
640

Loans, net of allowance
1,344,671

 

 

 
1,334,236

 
1,334,236

Bank owned life insurance
18,941

 

 
18,941

 

 
18,941

Accrued interest receivable
5,449

 

 
5,449

 

 
5,449

 
 
 
 
 
 
 
 
 
 
Financial Liabilities:
 

 
 

 
 

 
 

 
 

Deposits
$
1,566,227

 
$

 
$
1,570,721

 
$

 
$
1,570,721

Repurchase agreements
35,243

 

 
35,243

 

 
35,243

Junior subordinated debt
27,927

 

 

 
22,577

 
22,577

Accrued interest payable
795

 

 
795

 

 
795

Derivative - cash flow hedges
804

 

 
804

 

 
804